Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 5/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.40 |
| ▸ | CNR1 | P21554 | 4/20 | 0.38 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20763967 | 0.91 | CA1 (0.48) | CA1CA2DPP7DPP8SLC15A1 | |
| SCHEMBL24254128 | 0.84 | CNR1 (0.38) | CA1CA2DPP7DPP8SLC15A1 | |
| SCHEMBL13337034 | 0.82 | ACE (0.38) | CA1CA2DPP8DPP4DPP9 | |
| SCHEMBL12035287 | 0.80 | SIRT6 (0.44) | CA1CA2 | |
| SCHEMBL12975772 | 0.77 | ACE (0.40) | CA1CA2DPP8DPP4DPP9 | |
| SCHEMBL24713146 | 0.77 | ACE (0.40) | CA1CA2DPP8DPP4DPP9 | |
| SCHEMBL7269781 | 0.77 | MEN1 (0.48) | CA1CA2DPP7DPP8SLC15A1 | |
| SCHEMBL24922870 | 0.76 | DPP7 (0.44) | CA1CA2DPP7DPP8SLC15A1 | |
| SCHEMBL22807628 | 0.76 | ENPEP (0.46) | CA1CA2DPP7DPP8SLC15A1 | |
| SCHEMBL17424368 | 0.75 | SIRT6 (0.49) | BIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220048946-A1 | CYCLIC TETRAPEPTIDE STEREOISOMERS | UNIV KANSAS (US) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048946-A1 | CYCLIC TETRAPEPTIDE STEREOISOMERS | OPRK1, IL15, OPRL1 | CA1 1775/4885CA2 4029/4885DPP7 1651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.